Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/AVBP/Capital expenditures

ARRIVENT BIOPHARMA, INC. (AVBP) Capital expenditures

ARRIVENT BIOPHARMA, INC. (AVBP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to AVBP

Source: SEC XBRL filings · For reference only · Not investment advice

More AVBP financial trends

AVBP RevenueAVBP Net incomeAVBP Net marginAVBP Gross profitAVBP Gross marginAVBP Operating incomeAVBP Operating marginAVBP Operating cash flowAVBP Free cash flowAVBP Return on equityAVBP Stock buybacksAVBP Dividends paidAVBP Total assetsAVBP Total liabilitiesAVBP Shareholders’ equityAVBP overview →